[1]王玉玲,崔向宁,向 密,等.从“心部于表”论风药治疗冠心病[J].陕西中医,2023,(11):1577-1580.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.019]
 WANG Yuling,CUI Xiangning,XIANG Mi,et al.Treatment of coronary heart disease with wind medicine from “heart part in surface”[J].,2023,(11):1577-1580.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.019]
点击复制

从“心部于表”论风药治疗冠心病
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年11期
页码:
1577-1580
栏目:
学术探讨
出版日期:
2023-11-05

文章信息/Info

Title:
Treatment of coronary heart disease with wind medicine from “heart part in surface”
作者:
王玉玲12崔向宁1向 密1沈子焕12陈 琛1焦林珂12丁 帆12
(1.中国中医科学院广安门医院,北京100053; 2.北京中医药大学,北京 100029)
Author(s):
WANG YulingCUI XiangningXIANG MiSHEN ZihuanCHEN ChenJIAO LinkeDING Fan
(Guang 'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)
关键词:
冠心病 心部于表 风药 祛风散邪 通络止痛
Keywords:
Coronary heart disease Heart part in surface Wind pharmacology Qufeng Sanxie Tongluo Zhitong
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7369.2023.11.019
文献标志码:
A
摘要:
“心部于表”是对心的生理功能与表从属关系的高度概括。“心部于表”与肾治于里相对而言,阳主外,主动,意为心脏调节在表的阳气,而肾脏统摄在内的阴气,两者内外协调而使气血阴阳相顺接,维持人体正常生理功能。又心藏神,主血脉,为五脏六腑之主,主宰人体生命活动,心阳、心气鼓动气血津液外舍于周身,沟通表里,为心藏神提供物质基础。若心阳、心气受损,邪由表入,或邪由内生,风痰瘀血等病理产物损伤络脉,或直中心脉,皆可导致心脏受损。风之轻而气盛者,皆属风药。不仅具有开泄腠理,发散外邪之功,还可畅达阳气,行气胜湿,化瘀通络,醒神开窍,药力直趋病所。疏风散邪以理经通络,运转气机而畅通血脉之心; 又可振奋阳气,化瘀解郁而恢复心之神识; 前可畅达肝脾气机,燥湿醒脾,调和气血而助心之功能恢复。基于“心部于表”的理论内涵,探索风药理心之功,为临床治疗冠心病提供参考。
Abstract:
“Heart part in surface” is a high generalization of physiological function in heart and the relationship between surface.“Heart part in surface” and kidney treatment in relative,Yang master outside,active,meaning heart regulates Yangqi in table,and kidney controls Yinqi,both internal and external coordination and make the Qixue Yinyang phase connection,maintain normal physiological function.And the heart hides Shen and blood,the master of Wuzang Liufu and human life activities.Xinyang Xinqi encourages Qixue Jinye outside body communication surface.Provide material basis for mind to hide Shen.If Xinyang and Xinqi damaged,evil enters from surface,or evil comes from internal,and pathological products damage choroid veinsuch as Fengtan Yuxue or straight central pulseleading to heart damage.The light of wind and energeticare wind medicine.It not only has function of opening and draining Couli diverging the evil,reach Yangqi,Xingqi Shengshi,Huayu Tongluo,Xingshen Kaiqiao.Dispersing wind and evil to clear channels and collaterals,running Qi and unblocking heart of blood vessels.It can also stimulate Yangqi,dispelling stasis depression and restoring spiritual consciousness of heart.Before it can reach Ganpi Qiji,dry and wet awake spleen,harmonizing Qixue helping restore heart function.Based on the connotation of “heart part in surface” explores the function of wind pharmacology and heart for clinical treatment of coronary heart disease.

参考文献/References:

[1] Hasbani NR,Ligthart S,Brown MR,et al.American heart association's life's simple 7:Lifestyle recommendations polygenic risk and lifetime risk of coronary heart disease[J].Circulation,2022,145(11):808-818.
[2] 《中国心血管健康与疾病报告2021》编写组.《中国心血管健康与疾病报告2021》概述[J].中国心血管病研究,2022,20(7):577-596.
[3] 国家卫生计生委合理用药专家委员会,中国药师协会.冠心病合理用药指南[J].中国医学前沿杂志:电子版,2018,10(6):1-130.
[4] 王明杰,黄淑芬.风药增效论[J].新中医,2006,38(1):1-4.
[5] 杨保香,黄飞翔.从《内经》“心部于表”论病毒性心肌炎[J].国医论坛,2021,36(5):15-16.
[6] 吴 迪,李文彬,闫小宁,等.基于“心部于表”理论探析银屑病[J].陕西中医,2023,44(3):348-351.
[7] 崔 琰,李兰珍,段永强.谈“心部于表”[J].中医研究,2019,32(10):2-4.
[8] 戴国华.冠心病风病说[J].山东中医药大学学报,2003,27(3):172-174.
[9] 范 磊,张成博,杨海燕.“心部于表”的理论认识及其临床意义[J].山东中医药大学学报,2005,29(4):261-262.
[10] 林天溥.风药的作用机理及临床运用[J].浙江中医杂志,2006,41(10):604.
[11] 林秋蓉.李东垣“风药”理论及在脾胃病中的应用研究[D].成都:成都中医药大学,2018.
[12] 刘婉文,王保华,李赛美.风药在六经病辨治中的应用探讨[J].中华中医药杂志,2022,37(4):2072-2075.
[13] 杜建忠.风药探微[J].内蒙古中医药,1993,12(1):35-36.
[14] 孙洪孝.中医治疗学原理[M].成都:四川科学技术出版社,1990:54-60.
[15] 白 雪,王小强,彭 娟.“风能胜湿理论”在冠心病论治中的运用[J].中医药学报,2016,44(5):79-80.
[16] 宋 健,曾进浩,刘友章,等.国医大师邓铁涛从脾论治重症肌无力临床经验[J].陕西中医,2022,43(12):1774-1777.
[17] 朱 爽,高嘉良,段 练,等.试论外感病邪与冠心病之间的关联[J].中西医结合心脑血管病杂志,2019,17(23):3826-3829.
[18] 张定恒.解表药治疗冠心病机理浅析[J].环球中医药,2009,2(2):94-95.
[19] 刘 鑫,于嘉祥,曲 超,等.基于双心医学理论和分子对接技术探讨柴胡-黄芩药对治疗冠心病的作用机制[J].辽宁中医药大学学报,2022,25(2):1-15.
[20] 吴 岭.络病八大证候辨证论治[J].疑难病杂志,2006,5(2):118-120.
[21] 秘红英,魏 聪,李红蓉,等.基于贝叶斯算法的吴以岭教授治疗冠心病心绞痛的病案分析研究[J].中国中西医结合杂志,2018,38(5):534-538.
[22] 李红梅,王 显.从“玄府-气血-络脉”新视点探讨动脉粥样硬化“络风内动”学说[J].中医杂志,2015,56(5):441-443.
[23] 原 雪,李福凤,王忆勤.湿邪与冠心病的关系[J].中华中医药学刊,2013,31(3):499-500.
[24] 张 蒙,董其美,沈建平,等.冠心病湿盛风引病机内涵阐微[J].南京中医药大学学报,2022,38(8):671-675.
[25] 石宇奇.基于气化理论探讨李东垣组方思路及其在冠心病痰湿证中的应用[D].天津:天津中医药大学,2020.
[26] 闫子安,杨 铮,陈 鑫,等.郭士魁活血化瘀学术思想治疗心绞痛探讨[J].北京中医药,2022,41(4):390-392.
[27] 王 宇.五龙通络解郁方治疗冠心病稳定型心绞痛合并抑郁症的研究[D].北京:北京中医药大学,2021.
[28] 孙国星,范 虹,高晶晶,等.长安雷氏心病痰瘀流派“痰瘀毒风”理论辨治高血压病[J].陕西中医,2022,43(12):1787-1789.
[29] 钟 霞,康 晨,滕 晶,等.从“玄府郁闭”探讨卒中后抑郁防治[J].辽宁中医药大学学报,2023,25(3):205-208.
[30] 胡 悫,刘中勇.刘中勇运用风药辨治冠心病经验举隅[J].中西医结合心脑血管病杂志,2020,18(14):2346-2348.

相似文献/References:

[1]朱 薇.通脉调脂方治疗冠心病稳定性心绞痛疗效及对患者血流变、VCAM1〖JZ〗及ICAM1影响的研究*[J].陕西中医,2019,(3):290.
 ZHU Wei..Effect of Tongmai Tiaozhi recipe on the efficacy, Hemorheology, VCAM1 and ICAM1 〖JZ〗in patients with stable angina pectoris of coronary heart disease[J].,2019,(11):290.
[2]时晓华.丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*[J].陕西中医,2019,(5):568.
 SHI Xiaohua..Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease[J].,2019,(11):568.
[3]刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,(5):594.
 LIU Hong,ZHANG Lingyan,YANG Ling..Clinical observation of Xuefu Zhuyu decoction in the treatment of angina pectoris after PCI for coronary heart disease[J].,2019,(11):594.
[4]吕永飞,陈爱莲.益心康泰胶囊治疗冠心病经皮冠状动脉介入术术后疗效及对患者血流变、血管内皮功能的影响*[J].陕西中医,2019,(6):714.
 LV Yongfei,CHEN Ailian..Effect of Yixin Kangtai capsule on the curative effect hemorheology and vascular endothelial function after coronary artery disease PCI[J].,2019,(11):714.
[5]贺建涛,胡宇才,刘 磊.活血通络散治疗冠心病PCI术后心绞痛疗效研究*[J].陕西中医,2019,(7):854.
 HE Jiantao,HU Yucai,LIU Lei..Efficacy observation of Huoxue Tongluo powder in the treatment of angina pectoris after coronary heart disease PCI[J].,2019,(11):854.
[6]解洪涛,张 顺△,曾广伟.当归补血方联合西药治疗冠脉搭桥术后疗效及对患者血瘀证证候评分和凝血功能的影响*[J].陕西中医,2019,(10):1341.
 XIE Hongtao,ZHANG Shun,ZENG Guangwei..Effects of Danggui Buxue prescription combined with western medicine on blood stasis and coagulation function after coronary artery bypass grafting[J].,2019,(11):1341.
[7]索晓菲,王亚红△,王居新,等.软坚通脉汤治疗冠心病PCI术后Ⅱ期心脏康复疗效〖JZ〗及对患者生活质量的影响*[J].陕西中医,2020,(1):29.
[8]尹 毅,李小兰△.益气活血汤联合尼可地尔治疗稳定性心绞痛疗效及对患者T淋巴细胞亚群的影响[J].陕西中医,2020,(7):888.[doi:DOI:10.3969/j.issn.10007369.2020.07.014]
[9]季学清,刘 萍△,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究*[J].陕西中医,2020,(9):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
 JI Xueqing,LIU Ping,CHEN Baojin,et al.Efficacy of Guanxinkang preparation combined with western medicine in the treatment of coronary heart disease and type 2 diabetes mellitus with syndrome of Qixu Tanyu[J].,2020,(11):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
[10]董其浩,邓 兵.益脉强心汤对冠心病合并心衰患者心室重构及血清血小板活化因子、转化生长因子-β1的影响[J].陕西中医,2021,(7):883.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.018]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(81973842)
更新日期/Last Update: 2023-11-09